Building on this capability, we successfully generated human epidermal growth factor receptor 2 (HER2)-targeting CAR-M (HER2-CAR-M), which exhibited potent and specific anti-tumor activity in vitro. The gene discussed is ERBB2; the disease is neoplasm.